The current study provides evidence that epigenetic proxies of CRP and GDF15 exposure reflect the activation of immune/inflammation‐related pathways and are associated with longitudinal brain atrophy and cognitive decline as well as long‐term dementia risk. The gene discussed is CRP; the disease is Brain atrophy.